At Long Last, FDA Approves Effective Sunscreen
WASHINGTON (AFP) - US health officials approved a sunscreen product said to protect against a type of radiation linked to skin damage and cancer.
The Food and Drug Administration said it was approving L'Oreal's Anthelios SX for the prevention of sunburn by blocking both ultraviolet A and B (UVB) rays.
Most other products in the US market protect only against UVB, which is most commonly associated with sunburn.
"Most people think about UVB rays as being the problem in terms of sun exposure. In reality, UVA accounts for over 80 percent of the damage that occurs to the skin in terms of aging, DNA damage and ultimately skin cancer," said Darrell Rigel, a New York University dermatologist, in a statement issued by L'Oreal.
The first L'Oreal product containing Mexoryl SX to be released in the U.S. market will be ANTHELIOS SX, a daily moisturizing cream with sunscreen that will be sold by the L'Oreal brand La Roche-Posay. The product will be sold from this Fall and will be available in select pharmacies and drugstores as well as doctors' offices. L'Oreal also intends to launch daily moisturizing products containing Mexoryl SX in some of its other brands in the future, and to introduce more sunscreen formulations containing Mexoryl SX.
I've been using Anthelios XL 60 sunscreen for some time now and I cannot recommend it highly enough.